These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Outcome of pregnancies in women with treated or untreated hyperprolactinemia. Rossi AM; Vilska S; Heinonen PK Eur J Obstet Gynecol Reprod Biol; 1995 Dec; 63(2):143-6. PubMed ID: 8903770 [TBL] [Abstract][Full Text] [Related]
49. [The influence of bromocriptine-induced pregnancy and delivery on infertile cases with pituitary microadenoma]. Aso T; Motohashi T; Takahashi A; Su JH; Matsuoka M; Horie K; Tojo S Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):459-68. PubMed ID: 6854094 [TBL] [Abstract][Full Text] [Related]
50. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy. Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107 [TBL] [Abstract][Full Text] [Related]
51. [Bromocriptine treatment of hyperprolactinemia]. Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221 [TBL] [Abstract][Full Text] [Related]
52. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)]. Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150 [TBL] [Abstract][Full Text] [Related]
53. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome. Ayalon D; Eckstein N; Avidan S; Eshel A; L'Hermite M; Caufriez A; Spitz I; Zylber-Haran E Gynecol Obstet Invest; 1983; 16(2):97-106. PubMed ID: 6413305 [TBL] [Abstract][Full Text] [Related]
54. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)]. Galvan G; Frick J; Irnberger T Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210 [TBL] [Abstract][Full Text] [Related]
56. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma]. Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164 [TBL] [Abstract][Full Text] [Related]
57. [Current status of gynecologic hormone therapy. Prolactin-induced disorders]. Schneider HP Arch Gynecol; 1985; 238(1-4):697-705. PubMed ID: 4073958 [No Abstract] [Full Text] [Related]
58. Effect of bromocriptine treatment on male infertility associated with hyperprolactinemia. Laufer N; Yaffe H; Margalioth EJ; Livshin J; Ben-David M; Schenker JG Arch Androl; 1981 Jun; 6(4):343-6. PubMed ID: 7247577 [TBL] [Abstract][Full Text] [Related]
59. Pregnancy in patients presenting with hyperprolactinaemia. Thorner MO; Edwards CR; Charlesworth M; Dacie JE; Moult PJ; Rees LH; Jones AE; Besser GM Br Med J; 1979 Sep; 2(6193):771-4. PubMed ID: 519192 [TBL] [Abstract][Full Text] [Related]
60. Regression of pituitary tumors, a possible effect of bromergocryptine. George SR; Burrow GN; Zinman B; Ezrin C Am J Med; 1979 Apr; 66(4):697-702. PubMed ID: 433974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]